MedPath

Measurement of plasma concentrations of yokukansan in form of suppository to healthy Japanese volunteers

Not Applicable
Conditions
healthy Japanese volunteers
Registration Number
JPRN-UMIN000012965
Lead Sponsor
issay Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

a) Patients who are allergic to medicines, or foods related to the test material of this trial b) Pregnant women, lactating women, or women who want to get pregnant during the trial period c) Patients who are enrolled in the other clinical trials before the agreement for the participation to this trial d) Patients who are judged not suitable to participate in this trial by physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time course of plasma levels of hirsuteine and geissoschizine methylether after enteric administration of yokukansan
Secondary Outcome Measures
NameTimeMethod
Time course of plasma levels of hirsuteine and geissoschizine methylether after oral administration of yokukansan
© Copyright 2025. All Rights Reserved by MedPath